Overview Bioequivalence Study Status: Completed Trial end date: 2013-07-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine if tablets manufactured at different sites have the same bioavailability, that is yield similar blood levels/concentrations of the drugs and are handled by the body similarly Phase: Phase 1 Details Lead Sponsor: AstraZenecaTreatments: MetforminSaxagliptin